Compound 1 was obtained as a dark yellow, amorphous powder. The molecular formula, C 39 H 44 O 17 was deduced by a quasimolecular ion peak at m/z 807.2455 [M+Na] + (calcd. for C 39 H 44 NaO 17 (Table 1) . Furthermore, the resonances characteristic of two anomeric protons were observed at  H 4.83 (d, J = 7.5 Hz, H-1) and 4.84 (br s, H-1), suggesting that the structure of 1 has two monosaccharides. Acid hydrolysis of 1 followed by GC analysis resulted in the identification of D-glucose and L-rhamnose [11] . The 1 H NMR coupling constant (J 1,2 = 7.5 Hz) of the anomeric proton was consistent with the -glucose, while the -rhamnose was deduced by comparing the carbon chemical shifts for C-3 and C-5 with those of the corresponding carbons of -and -rhamnopyranoside [12] . 168.4 (C-9) and 168.6 (C-9), two double bonds, one phenyl, and one para-substituted aromatic ring in the 13 C NMR spectrum indicated the presence of a trans-cinnamoyl and a trans-paracoumaroyl units in the molecule ( Table 1 ). The nine remaining carbons signals, including two olefinic carbons at  C 142.2 (C-3) and 103.5 (C-4), a hemiacetal carbon at  C 95.4 (C-1), an oxymethylene carbon at  C 61.6 (C-10), an epoxy group [ C 59.6 (C-7) and 66.4 (C-8)], and two methine carbons at  C 37.3 (C-5) and 43.2 (C-9) were assignable to the iridoid nucleus [13] . Based on this analysis and comparison of the 1 H and 13 C NMR data of 1 with those of the reported compounds in the literature [14], the structure of 1 was suggested to be an iridoid glycoside associated with a trans-cinnamoyl and a trans-para-coumaroyl unit. The assignment of all the positions was done by detailed analysis of HSQC, COSY, and HMBC spectra (Figure 2 ). The locations of the -glucose and -rhamnose at the C-1 and C-6 positions were deduced by HMBC correlations from δ H 4.83 (H-1) to δ C 95.4 (C-1) and from δ H 4.84 (H-1) to δ C 84.7 (C-6), respectively. The trans-cinnamoyl unit was located at C-6 as revealed based on an HMBC correlation from  H 4.57/4.48 (H 2 -6) to  C 168.4 (C-9). The location of the transpara-coumaroyl unit at C-2 was determined by an HMBC correlation from  H 5.12 (H-2) to  C 168.6 (C-9) and COSY correlations between H-1 and H-2. The relative configuration of 1 was determined by ROESY spectroscopic analysis (Figure 2 ). In the ROESY spectrum, an ROE correlation between H-5 and H-9 revealed that H-5 and H-9 are located on the same face of the molecule. H-1 showed an ROE cross-peak with H-6 but not with H-5, suggesting that H-1 and H-6 are -oriented. H-7 was shown to have ROE correlations with H-6 and H 2 -10 but not with both H-5 and H-9, suggesting that H-6, H-7, and H 2 -10 are oriented to the same side. Finally, the structure of 1 was established as 6 
-O-(2-Otrans-p-coumaroyl)--L-rhamnopyranosyl-(6-O-trans-cinnamoyl)-catalpol, named buddlejasiaside A.
The known secondary metabolites, including eight iridoid glycosides, 6-O-[-L-(4-isoferuloyl)rhamnopyranosylcatalpol (2) [15] , specioside (3) [16] , verminoside (4) [17] , minecoside (5) [17], 6-O-(p-hydroxybenzoyl)-ajugol (6) [18], 6-O-caffeoyl ajugol (7) [19] , litanthosalin (8) [20] , eurostoside (9) [21], 10-Ocaffeoylaucubin (10) [22] , and two phenolic glycosides, including phlorizin (11) [23] and garashangin (12) [24] were identified by NMR spectroscopic analyses and comparing with the data reported in the literature.
Nitric oxide (NO), a pro-inflammatory mediator is synthesized by its inducible enzyme iNOS in response to the presence of stimuli in the macrophages [25] . Excessive production of NO in the brain has been shown to be associated with many degenerative neurologic diseases, including Parkinson's disease, Alzheimer's diseases, multiple sclerosis, amyotrophic lateral sclerosis, AIDS, and dementia [26] . Therefore, inhibition of NO production is considered as one of the therapeutic approaches for the treatment of neuroinflammatory disorders. The inhibitory effects of the isolated compounds against nitrite production -the stable end product of NO oxidation in LPS-stimulated BV2 cells were evaluated using the Griess reaction [27] . Firstly, the viability of BV2 cells in response of the isolated compounds was examined by the MTT assay. The result showed that these compounds are nontoxic toward the cells at the tested concentrations (10-80 µM) (data not shown). Thus, the nitrite inhibitory effects of isolated compounds were then evaluated at the same concentration range. As indicated in Table 2 , compounds 1, 2, and 8-10 showed the modest inhibitory effects against nitrite production, with IC 50 values ranging from 43.5 -79.6 µM, whereas other compounds were inactive. Acid hydrolysis: Compound 1 was refluxed in 5% HCl at 80°C for 3 h. After drying in vacuo, the residues were partitioned between CH 2 Cl 2 and H 2 O. The aqueous layer was collected and dried in vacuo to give a residue. The residue was dissolved in anhydrous pyridine (100 mL) and mixed with a pyridine solution of 0.1 M L-cysteine methyl ester hydrochloride (100 mL) at 60°C for 2 h. A solution of trimethylsilylimidazole was then added and the reaction was incubated at 60°C for 2 h. The mixture was dried under reduced pressure and then partitioned between n-hexane and H 2 O. The n-hexane layer was filtered and analyzed by GC. The absolute configurations of the monosaccharides were identified as D-glucose and L-rhamnose by comparing the retention times of persilylated monosaccharide derivatives with those of standard samples.
Cell Culture and Viability Assay. BV2 microglia cells and mouse hippocampal HT22 cells were seeded at 5 × 10 5 cells/mL in DMEM medium supplemented with 10% heat-inactivated FBS, penicillin G (100 U/mL), streptomycin (100 mg/L), and L-glutamine (2 mM), and incubated at 37 °C in a humidified atmosphere containing 5% CO 2 . Cell viability was determined by adding 100 mg/mL of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) to 1 mL of a cell suspension (1 × 10 5 cells per 1 mL in 96-well plates) and incubated for 30 min. The formed formazan was dissolved in acidic 2-propanol, and the optical density was measured at 540 nm. For determination of cytoprotective effect, HT22 cells (5 × 10 5 cells/mL in DMEM medium) were pretreated with compounds in the presence of 5 mM glutamate and incubated for 12h and cell viability by MTT assay.
Nitrite (NO production) determination:
The nitrite concentration in the medium, an indicator of NO production, was measured with the Griess reaction. Briefly, the cells were pretreated for 30 min with different concentrations of compounds and then stimulated for 24 h with LPS (1 g/mL). Each cell supernatant (100 µL) was mixed with an equal volume of the Griess reagent (Solution A: 222488; Solution B: S438081, Sigma), and the absorbance of the mixture at 525 nm was measured using an ELISA plate reader.
Supplementary data: The HRESIMS and NMR spectra of the new compound can be found in the online version.
